Author: Fran Hawthorne
Edition: 1
Publisher: Wiley
Binding: Paperback
ISBN: 0471679062
The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant
An in-depth look at big pharma's flagship company
The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Medical books The Merck Druggernaut. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business Medical books The Merck Druggernaut. The Merck Druggernaut
Download link for The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant
The Merck Druggernaut
Electronics Cameras Computers Software Housewares Sports DVDs Music Books Games Toys in titles descriptions Company Info |Checkout Info |Shipping Info |Return Policy |FAQ's Add us as a favorite seller By continuing with your purchase using the eBay Buy It Now button, you agree to the Buy Terms of Use at http://stores.ebay.com/Buys-Internet-Superstore/Terms.html . The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant - Fran Hawthorne|Hawthorne, Fran THIS IS A BRAND NEW UNOPENED ITEM.
"The Merck Druggernaut" takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals.
MTS Books presents ... The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant ISBN: 0471228788 Author: Fran Hawthorne Publisher: Wiley Release Date: 2003-02-28 Seller Category: -- Qty Available: 1 Condition: New Sku: BR32D46 Notes: Brand new never read hardback book with dustjacket,very clean Don't forget to check out other great deals in our eBay Store!!
Medical Book The Merck Druggernaut
- ISBN13: 9780471679066
- Condition: New
- Notes: BRAND NEW FROM PUBLISHER! 100% Satisfaction Guarantee. Tracking provided on most orders. Buy with Confidence! Millions of books sold!
Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business.
Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year.
